project id: TCGA-PRAD; case submitter id: TCGA-EJ-A6RC; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.88; age at index: 64; days to birth: -23598; ethnicity: not reported; gender: male; race: white; vital status: Alive; year of birth: 1947; age at diagnosis: 23598; ajcc clinical m: M0; ajcc clinical t: T1c; ajcc pathologic n: N0; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 873.0; icd 10 code: C61; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; primary gleason grade: Pattern 4; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; secondary gleason grade: Pattern 3; site of resection or biopsy: Prostate gland; synchronous malignancy: No; tissue or organ of origin: Prostate gland; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; days to collection: 631; initial weight: 450.0; sample id: b79ed761-77ef-4abb-9c52-344eca9bc08e; sample submitter id: TCGA-EJ-A6RC-01A; portion id: 4d8d87a8-4d52-4b4f-8c8b-ac5f7390a4b0; portion submitter id: TCGA-EJ-A6RC-01A-11; slide id: ce54a4f9-3819-40df-bfbe-97244505966f; slide submitter id: TCGA-EJ-A6RC-01A-01-TSA; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 40.0; percent stromal cells: 10.0; percent tumor cells: 50.0; percent tumor nuclei: 60.0; section location: TOP;